PDL BIOPHARMA | 5,154 Euro | +0,011 +0,21 % | |
| WKN: A0H1J1 ISIN: US69329Y1047 Ticker-Symbol: PDL | Stuttgart | 28.05.12 | 08:04 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 27.05. | Shares of PDL BioPharma Rank the Highest in Terms of Earnings Yield in the Biotechnology Industry | 2 | SmarTrend | |
| 21.05. | PDL BioPharma is Among the Companies in the Biotechnology Industry With the Lowest P/E Ratio | 15 | SmarTrend | |
| 08.05. | Earnings Beat at PDL BioPharma | 24 | Zacks | |
| 08.05. | PDL BioPharma to Present at Upcoming Conferences | 30 | PR Newswire | |
| INCLINE VILLAGE, Nev., May 8, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, is scheduled... Mehr lesen zu: PDL BioPharma to Present at Upcoming Conferences | ||||
| 08.05. | Highest Forward Earnings Yield in the Biotechnology Industry Detected in Shares of PDL BioPharma | 5 | SmarTrend | |
| 04.05. | PDL BioPharma's CEO Discusses Q1 2012 Results - Earnings Call Transcript | 8 | Seeking Alpha | |
| 04.05. | PDL BioPharma Q1 Profit Falls | 75 | AFX News | |
| WASHINGTON (dpa-AFX) - PDL BioPharma (PDLI) reported first-quarter net
income of $40.1 million, down from $44.5 million last year. Earnings per share
was $0.29 compared to $0.25 per share... Mehr lesen zu: PDL BioPharma Q1 Profit Falls | ||||
| 03.05. | PDL BioPharma Announces First Quarter 2012 Financial Results | 33 | PR Newswire | |
| INCLINE VILLAGE, Nev., May 3, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2012.
(Logo:http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)... Mehr lesen zu: PDL BioPharma Announces First Quarter 2012 Financial Results | ||||
| 02.05. | Whisper Number Impact: Earnings Preview For Cardinal Health, Cigna, PDL BioPharma | 4 | Seeking Alpha | |
| 30.04. | Relatively High Revenue Per Employee Detected in Shares of PDL BioPharma in the Biotechnology Industry | 7 | SmarTrend | |
| 27.04. | PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012 | 97 | PR Newswire | |
| INCLINE VILLAGE, Nev., April 27, 2012 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its first quarter financial results for the period... Mehr lesen zu: PDL BioPharma to Announce First Quarter 2012 Financial Results on May 3, 2012 | ||||
| 26.04. | PDL BioPharma Appoints Bruce Tomlinson as Chief Financial Officer | 16 | PR Newswire | |
| INCLINE VILLAGE, Nev., April 26, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company has appointed Bruce Tomlinson to the position of vice president... Mehr lesen zu: PDL BioPharma Appoints Bruce Tomlinson as Chief Financial Officer | ||||
| 12.04. | PDL BioPharma to Hold Annual Meeting of Stockholders on June 5, 2012 | 30 | PR Newswire | |
| INCLINE VILLAGE, Nev., April 12, 2012 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company will hold its annual meeting of stockholders on Tuesday, June 5, 2012... Mehr lesen zu: PDL BioPharma to Hold Annual Meeting of Stockholders on June 5, 2012 | ||||
| 29.03. | Highest Revenue Per Employee in the Biotechnology Industry Detected in Shares of PDL BioPharma | 6 | SmarTrend | |
| 14.03. | PDL BioPharma Completes Regular Quarterly Dividend Payment | 57 | PR Newswire | |
| INCLINE VILLAGE, Nev., March 14, 2012 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 14, 2012, regular quarterly dividend payment of... Mehr lesen zu: PDL BioPharma Completes Regular Quarterly Dividend Payment | ||||
| 08.03. | PDL BioPharma Provides Q1 Revenue Guidance | 68 | AFX News | |
| WASHINGTON (dpa-AFX) - PDL BioPharma, Inc. (PDLI) announced royalty revenue
guidance for the first quarter ending March 31, 2012, of approximately $77
million, as compared with actual royalty... Mehr lesen zu: PDL BioPharma Provides Q1 Revenue Guidance | ||||
| 08.03. | PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million | 41 | PR Newswire | |
| INCLINE VILLAGE, Nev., March 8, 2012 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced royalty revenue guidance for the first quarter ending March 31, 2012, of approximately... Mehr lesen zu: PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million | ||||
| 05.03. | PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes | 51 | PR Newswire | |
| INCLINE VILLAGE, Nev., March 5, 2012 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for its:
2.875% Convertible Senior Notes due February... Mehr lesen zu: PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes | ||||
| 05.03. | XFRA DIVIDEND INFORMATION - 05.03.2012 - 3 | 248 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 05.03.2012 EX DIVIDENDE GEHANDELT. THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 05.03.2012. INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT DJFJ XFRA DE0008475039... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 05.03.2012 - 3 | ||||
| 02.03. | XFRA DIVIDEND INFORMATION - 05.03.2012 - 1 | 376 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 02.03.2012 CUM DIVIDENDE UND AM 05.03.2012 EX DIVIDENDE GEHANDELT. THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 02.03.2012. THE EX-DIVIDEND DAY WILL BE 05.03.2012.... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 05.03.2012 - 1 | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC | 51,82 | +0,21 % | Vertex Announces Webcast of its Presentations at Two Investor Conferences |
| STADA ARZNEIMITTEL AG | 24,840 | -0,64 % | Kepler hebt Ziel für Stada auf 32 Euro - 'Buy' |
| GILEAD SCIENCES INC | 40,630 | +1,40 % | Erfolg für GILEAD |
| CELGENE CORPORATION | 55,07 | -0,59 % | Celgene Corporation to Present at Sanford C. Bernstein's 28th Annual Strategic Decisions Conference |
| CELESIO AG | 11,750 | +0,30 % | Celesio AG: Neues 13-Wochentief (11.71 Euro, Short) |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
